Roberto Latagliata

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Venues

Hematological oncology

European journal of haematology

Journal of clinical medicine

Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Costa, Elisabetta Abruzzese, Roberto Latagliata, Olga Mulas, Ida Carmosino, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Giovanni Caocci, Massimo Breccia
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of clinical medicine 13 (1) (2024)
Alessandro Costa, Elisabetta Abruzzese, Roberto Latagliata, Olga Mulas, Ida Carmosino, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Giovanni Caocci, Massimo Breccia
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of clinical medicine 13 (1) (2024)
Giulio Trapè, Gioia De Angelis, Marco Morucci, Michela Tarnani, Cinzia De Gregoris, Ambra Di Veroli, Valentina Panichi, Giuseppe Topini, Loredana Bassi, Raffaella Isidori, Monica Poscente, Vincenza Innocenti, Elisa Emanueli Cippitelli, Roberta Talucci, Silvia Bertelli, Alessandra Crocicchia, Annalisa Lippi, Giulia Pezzuti, Michela Fuschino, Raffaella Randi, Cristina Mastini, Silvia Ciambella, Gloria Pessina, Marco Montanaro, Roberto Latagliata
Treatment in patients with acute myeloid leukemia/high-risk myelodysplastic syndrome with hypomethylating agents: Day-hospital management compared to home care setting. European journal of haematology (2023)
Esther Natalie Oliva, Anna Candoni, Prassede Salutari, Giuseppe Alberto Maria Palumbo, Gianluigi Reda, Giuseppe Iannì, Giovanni Tripepi, Maria Cuzzola, Debora Capelli, Corrado Mammì, Caterina Alati, Maria Concetta Cannatà, Pasquale Niscola, Bianca Serio, Pellegrino Musto, Ernesto Vigna, Antonio Volpe, Lorella Maria Antonia Melillo, Maria Teresa Arcadi, Donato Mannina, Maria Elena Zannier, Roberto Latagliata
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE). Cancers 15 (9) (2023)
Mario Tiribelli, Roberto Latagliata, Massimo Breccia, Isabella Capodanno, Maria Cristina Miggiano, Francesco Cavazzini, Cristina Bucelli, Immacolata Attolico, Sabrina Leonetti Crescenzi, Sabina Russo, Mario Annunziata, Federica Sorà, Massimiliano Bonifacio, Olga Mulas, Giuseppina Loglisci, Alessandro Maggi, Gianni Binotto, Elena Crisà, Anna Rita Scortechini, Anna Paola Leporace, Rosaria Sancetta, Pamela Murgano, Elisabetta Abruzzese, Fabio Stagno, Davide Rapezzi, Debora Luzi, Iolanda Vincelli, Monica Bocchia, Carmen Fava, Alessandra Malato, Monica Crugnola, Michele Pizzuti, Francesca Lunghi, Sara Galimberti, Matteo Dalmazzo, Renato Fanin, Emilia Scalzulli, Robin Foà, Alessandra Iurlo, Giuseppe Saglio, Giorgina Specchia
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML. Cancer (2023)
Francesca Palandri, Elena Rossi, Giuseppe Auteri, Massimo Breccia, Simona Paglia, Giulia Benevolo, Elena Maria Elli, Francesco Cavazzini, Gianni Binotto, Alessia Tieghi, Mario Tiribelli, Florian H Heidel, Massimiliano Bonifacio, Novella Pugliese, Giovanni Caocci, Monica Crugnola, Francesco Mendicino, Alessandra D'Addio, Simona Tomassetti, Bruno Martino, Nicola Polverelli, Sara Ceglie, Camilla Mazzoni, Rikard Mullai, Alessia Ripamonti, Bruno Garibaldi, Fabrizio Pane, Antonio Cuneo, Mauro Krampera, Gianpietro Semenzato, Roberto M Lemoli, Nicola Vianelli, Giuseppe Alberto Maria Palumbo, Alessandro Andriani, Michele Cavo, Roberto Latagliata, Valerio De Stefano
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study. Cancers 15 (14) (2023)
Esther Natalie Oliva, Anna Candoni, Prassede Salutari, Giuseppe Alberto Maria Palumbo, Gianluigi Reda, Giuseppe Iannì, Giovanni Tripepi, Maria Cuzzola, Debora Capelli, Corrado Mammì, Caterina Alati, Maria Concetta Cannatà, Pasquale Niscola, Bianca Serio, Pellegrino Musto, Ernesto Vigna, Antonio Volpe, Lorella Maria Antonia Melillo, Maria Teresa Arcadi, Donato Mannina, Maria Elena Zannier, Roberto Latagliata
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE). Cancers 15 (9) (2023)
Elena Maria Elli, Ambra Di Veroli, Daniela Bartoletti, Alessandra Iurlo, Ida Carmosino, Giulia Benevolo, Elisabetta Abruzzese, Massimiliano Bonifacio, Micaela Bergamaschi, Nicola Polverelli, Marianna Caramella, Daniela Cilloni, Mario Tiribelli, Novella Pugliese, Giovanni Caocci, Elena Crisà, Raffaele Porrini, Uros Markovic, Rossella Renso, Giuseppe Auteri, Daniele Cattaneo, Malgorzata Monika Trawinska, Luigi Scaffidi, Lucia Biale, Cristina Bucelli, Massimo Breccia, Carlo Gambacorti-Passerini, Giuseppe Alberto Palumbo, Roberto Latagliata, Francesca Palandri
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study. British journal of haematology 197 (2) (2022)
Alessia Campagna, Daniela De Benedittis, Luana Fianchi, Emilia Scalzulli, Lorenzo Rizzo, Pasquale Niscola, Anna Lina Piccioni, Ambra Di Veroli, Stefano Mancini, Nicoletta Villivà, Tiziano Martini, Sara Mohamed, Ida Carmosino, Marianna Criscuolo, Susanna Fenu, Maria Antonietta Aloe Spiriti, Francesco Buccisano, Marco Mancini, Agostino Tafuri, Massimo Breccia, Antonella Poloni, Roberto Latagliata
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity? Journal of clinical medicine 11 (9) (2022)
Roberto Latagliata, Immacolata Attolico, Malgorzata Monika Trawinska, Isabella Capodanno, Mario Annunziata, Chiara Elena, Luigiana Luciano, Monica Crugnola, Micaela Bergamaschi, Massimiliano Bonifacio, Claudia Baratè, Endri Mauro, Gianni Binotto, Nicola Sgherza, Chiara Aguzzi, Barbara Monteleone, Federica Sorà, Giovanni Caocci, Debora Luzi, Elena Mariggiò, Luigi Scaffidi, Daniele Cattaneo, Antonella Gozzini, Ambra Di Veroli, Elisabetta Abruzzese, Sara Galimberti, Alessandra Iurlo, Giorgina Specchia, Massimo Breccia
Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors. Hematological oncology 39 (3) (2021)
Massimo Breccia, Elisabetta Abruzzese, Vincenzo Accurso, Immacolata Attolico, Sara Barulli, Micaela Bergamaschi, Gianni Binotto, Monica Bocchia, Massimiliano Bonifacio, Giovanni Caocci, Isabella Capodanno, Fausto Castagnetti, Francesco Cavazzini, Elena Crisà, Monica Crugnola, Maria Stella De Candia, Chiara Elena, Carmen Fava, Sara Galimberti, Antonella Gozzini, Gabriele Gugliotta, Tamara Intermesoli, Alessandra Iurlo, Gaetano La Barba, Roberto Latagliata, Sabrina Leonetti Crescenzi, Luciano Levato, Giuseppina Loglisci, Alessandro Lucchesi, Luigiana Luciano, Francesca Lunghi, Debora Luzi, Alessandra Malato, Maria Cristina Miggiano, Michele Pizzuti, Patrizia Pregno, Davide Rapezzi, Giovanna Rege-Cambrin, Gianantonio Rosti, Sabina Russo, Rosaria Sancetta, Anna Rita Scortechini, Federica Sorà, Paolo Sportoletti, Fabio Stagno, Agostino Tafuri, Mario Tiribelli, Robin Foà, Giuseppe Saglio
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. British journal of haematology (2021)
Giulia Benevolo, Elena M Elli, Daniela Bartoletti, Roberto Latagliata, Mario Tiribelli, Florian H Heidel, Francesco Cavazzini, Massimiliano Bonifacio, Monica Crugnola, Gianni Binotto, Alessandra D'Addio, Alessia Tieghi, Micaela Bergamaschi, Giovanni Caocci, Nicola Polverelli, Elisa Bossi, Giuseppe Auteri, Ida Carmosino, Lucia Catani, Antonio Cuneo, Mauro Krampera, Francesco Lanza, Roberto M Lemoli, Nicola Vianelli, Massimo Breccia, Giuseppe A Palumbo, Michele Cavo, Francesca Palandri
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients. Hematological oncology 39 (3) (2021)
Francesca Palandri, Mario Tiribelli, Massimo Breccia, Daniela Bartoletti, Elena M Elli, Giulia Benevolo, Bruno Martino, Francesco Cavazzini, Alessia Tieghi, Alessandra Iurlo, Elisabetta Abruzzese, Novella Pugliese, Gianni Binotto, Giovanni Caocci, Giuseppe Auteri, Daniele Cattaneo, Malgorzata M Trawinska, Rossella Stella, Luigi Scaffidi, Nicola Polverelli, Giorgia Micucci, Elena Masselli, Monica Crugnola, Costanza Bosi, Florian H Heidel, Roberto Latagliata, Fabrizio Pane, Antonio Cuneo, Mauro Krampera, Gianpietro Semenzato, Roberto M Lemoli, Michele Cavo, Nicola Vianelli, Massimiliano Bonifacio, Giuseppe Alberto Maria Palumbo
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome. Cancer 127 (15) (2021)
Francesca Palandri, Massimo Breccia, Mario Tiribelli, Massimiliano Bonifacio, Giulia Benevolo, Alessandra Iurlo, Elena M Elli, Gianni Binotto, Alessia Tieghi, Nicola Polverelli, Bruno Martino, Elisabetta Abruzzese, Micaela Bergamaschi, Florian H Heidel, Francesco Cavazzini, Monica Crugnola, Costanza Bosi, Alessandro Isidori, Giuseppe Auteri, Dorian Forte, Roberto Latagliata, Davide Griguolo, Daniele Cattaneo, Malgorzata Trawinska, Daniela Bartoletti, Mauro Krampera, Gianpietro Semenzato, Roberto M Lemoli, Antonio Cuneo, Francesco Di Raimondo, Nicola Vianelli, Michele Cavo, Giuseppe A Palumbo
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data. Hematological oncology 38 (3) (2020)
Roberto Latagliata, Pasquale Niscola, Luana Fianchi, Maria Antonietta Aloe Spiriti, Luca Maurillo, Ida Carmosino, Laura Cesini, Chiara Sarlo, Annalina Piccioni, Alessia Campagna, Maria Lucia De Luca, Daniela De Benedittis, Marco Mancini, Massimo Breccia, Marianna Criscuolo, Francesco Buccisano, Maria Teresa Voso, Giuseppe Avvisati, Agostino Tafuri, Paolo De Fabritiis, Robin Foà, Corrado Girmenia
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment. Hematological oncology 38 (2) (2020)
Maria Gabriella Mazzucconi, Ermina Baldacci, Roberto Latagliata, Massimo Breccia, Francesca Paoloni, Ambra Di Veroli, Michele Cedrone, Barbara Anaclerico, Nicoletta Villivà, Raffaele Porrini, Enrico Montefusco, Alessandro Andriani, Marco Montanaro, Laura Scaramucci, Antonio Spadea, Angela Rago, Giuseppe Cimino, Francesca Spirito, Cristina Santoro
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group". European journal of haematology 105 (3) (2020)
Laura Cesini, Camilla Frieri, Claudia Baratè, Federica Sorà, Massimiliano Bonifacio, Marco Cerrano, Antonia Cagnetta, Chiara Elena, Lara Aprile, Nicola Sgherza, Malgorzata Trawinska, Antonella Gozzini, Isabella Capodanno, Monica Crugnola, Ida Carmosino, Emilia Scalzulli, Federica Ricci, Monica Bocchia, Micaela Bergamaschi, Chiara Aguzzi, Simona Sica, Sara Galimberti, Massimo Breccia, Luigiana Luciano, Roberto Latagliata
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia. European journal of haematology 105 (3) (2020)
Gioia Colafigli, Emilia Scalzulli, Marika Porrazzo, Daniela Diverio, Maria Giovanna Loglisci, Roberto Latagliata, Anna Guarini, Robin Foà, Massimo Breccia
Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome. Hematological oncology 37 (5) (2019)
Francesca Palandri, Giuseppe A Palumbo, Elisabetta Abruzzese, Alessandra Iurlo, Nicola Polverelli, Elena Elli, Massimiliano Bonifacio, Micaela Bergamaschi, Bruno Martino, Mario Tiribelli, Giulia Benevolo, Alessia Tieghi, Nicola Sgherza, Alessandro Isidori, Gianni Binotto, Monica Crugnola, Florian Heidel, Francesco Cavazzini, Costanza Bosi, Giuseppe Auteri, Daniele Cattaneo, Robin Foà, Roberto M Lemoli, Antonio Cuneo, Mauro Krampera, Daniela Bartoletti, Michele Cavo, Nicola Vianelli, Massimo Breccia, Roberto Latagliata
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib. Hematological oncology 37 (4) (2019)
Francesca Palandri, Massimo Breccia, Massimiliano Bonifacio, Nicola Polverelli, Elena M Elli, Giulia Benevolo, Mario Tiribelli, Elisabetta Abruzzese, Alessandra Iurlo, Florian H Heidel, Micaela Bergamaschi, Alessia Tieghi, Monica Crugnola, Francesco Cavazzini, Gianni Binotto, Alessandro Isidori, Nicola Sgherza, Costanza Bosi, Bruno Martino, Roberto Latagliata, Giuseppe Auteri, Luigi Scaffidi, Davide Griguolo, Malgorzata Trawinska, Daniele Cattaneo, Lucia Catani, Mauro Krampera, Roberto M Lemoli, Antonio Cuneo, Gianpietro Semenzato, Robin Foà, Francesco Di Raimondo, Daniela Bartoletti, Michele Cavo, Giuseppe A Palumbo, Nicola Vianelli
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis. Cancer 126 (6) (2019)
Monica Bocchia, Anna Candoni, Erika Borlenghi, Marzia Defina, Carla Filì, Chiara Cattaneo, Vincenzo Sammartano, Renato Fanin, Margherita Sciumè, Anna Sicuranza, Silvia Imbergamo, Marta Riva, Nicola Fracchiolla, Roberto Latagliata, Emanuela Caizzi, Francesco Mazziotta, Giulia Alunni, Eros Di Bona, Monica Crugnola, Marianna Rossi, Ugo Consoli, Giulia Fontanelli, Giuseppina Greco, Gianpaolo Nadali, Francesco Rotondo, Elisabetta Todisco, Catia Bigazzi, Enrico Capochiani, Alfredo Molteni, Massimo Bernardi, Monica Fumagalli, Michela Rondoni, Barbara Scappini, Anna Ermacora, Federico Simonetti, Michele Gottardi, Daniela Lambertenghi Deliliers, Mariagrazia Michieli, Claudia Basilico, Carlotta Galeone, Claudio Pelucchi, Giuseppe Rossi
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy. Hematological oncology 37 (4) (2019)
Alessandro Andriani, Elena Elli, Giulio Trapè, Nicoletta Villivà, Luana Fianchi, Ambra Di Veroli, Pasquale Niscola, Antonia Centra, Barbara Anaclerico, Guido Montanaro, Vincenza Martini, Andrea Aroldi, Ida Carmosino, Maria Teresa Voso, Massimo Breccia, Marco Montanaro, Roberto Foà, Roberto Latagliata
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors. Hematological oncology 37 (3) (2019)
Roberto Latagliata, Massimo Breccia, Ida Carmosino, Laura Cesini, Daniela De Benedittis, Sara Mohamed, Federico Vozella, Matteo Molica, Melissa Campanelli, Maria Lucia De Luca, Gioia Colafigli, Luisa Quattrocchi, Maria Giovanna Loglisci, Fulvio Massaro, Martina Canichella, Daniela Diverio, Marco Mancini, Giuliana Alimena, Robin Foà
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse? European journal of haematology (2018)
Rena Buckstein, Enrico Balleari, Richard Wells, Valeria Santini, Alessandro Sanna, Chiara Salvetti, Elena Crisà, Bernardino Allione, Paolo Danise, Carlo Finelli, Marino Clavio, Antonella Poloni, Flavia Salvi, Daniela Cilloni, Esther Natalie Oliva, Pellegrino Musto, Brett Houston, Nancy Zhu, Michelle Geddes, Heather Leitch, Brian Leber, Mitchell Sabloff, Thomas J Nevill, Karen W Yee, John M Storring, Janika Francis, Luca Maurillo, Roberto Latagliata, Maria Antonietta Aloe Spiriti, Alessandro Andriani, Anna Lina Piccioni, Luana Fianchi, Susanna Fenu, Svitlana Gumenyuk, Francesco Buccisano
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems. American journal of hematology 92 (10) (2017)
Matteo Molica, Martina Canichella, Danilo Alunni Fegatelli, Gioia Colafigli, Fulvio Massaro, Roberto Latagliata, Robin Foà, Massimo Breccia
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials. American journal of hematology 92 (12) (2017)
Massimo Breccia, Gioia Colafigli, Matteo Molica, Emilia Scalzulli, Daniela Diverio, Roberto Latagliata, Anna Guarini, Robin Foà
Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life. American journal of hematology 92 (12) (2017)
Cristina Santoro, Isabella Sperduti, Roberto Latagliata, Erminia Baldacci, Barbara Anaclerico, Giuseppe Avvisati, Massimo Breccia, Francesco Buccisano, Michele Cedrone, Giuseppe Cimino, Cinzia De Gregoris, Marianna De Muro, Ambra Di Veroli, Sabrina Leonetti Crescenzi, Marco Montanaro, Enrico Montefusco, Raffaele Porrini, Angela Rago, Antonio Spadea, Francesca Spirito, Nicoletta Villivà, Alesssandro Andriani, Giuliana Alimena, Maria Gabriella Mazzucconi
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia. Cancer medicine 6 (6) (2017)

Roberto Latagliata.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Roberto Latagliata